Bo Nilsson

Q: What Schools Are Affiliated With Bo Nilsson

Bo Nilsson is affiliated with the following schools: Uppsala University, University of Gothenburg, Lund University

Bo Nilsson's AcademicInfluence.com Rankings

Bo Nilsson

Computer Science

#7218

World Rank

#7601

Historical Rank

Computational Linguistics

#1401

World Rank

#1417

Historical Rank

Machine Learning

#2598

World Rank

#2633

Historical Rank

Artificial Intelligence

#2890

World Rank

#2935

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Why Is Bo Nilsson Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Bo Nilsson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Molecular Intercommunication between the Complement and Coagulation Systems (2010) (626)
Complement and coagulation: strangers or partners in crime? (2007) (591)
Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation (2002) (555)
Structures of complement component C3 provide insights into the function and evolution of immunity (2005) (518)
Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? (1999) (437)
The role of complement in biomaterial-induced inflammation. (2007) (414)
Isolated Human Islets Trigger an Instant Blood Mediated Inflammatory Reaction: Implications for Intraportal Islet Transplantation as a Treatment for Patients with Type 1 Diabetes (2000) (333)
Do Cryopreserved Mesenchymal Stromal Cells Display Impaired Immunomodulatory and Therapeutic Properties? (2014) (285)
Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation. (2002) (267)
Are Therapeutic Human Mesenchymal Stromal Cells Compatible with Human Blood? (2012) (263)
CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery (2012) (223)
Islet Surface Heparinization Prevents the Instant Blood-Mediated Inflammatory Reaction in Islet Transplantation (2007) (221)
Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. (2005) (210)
Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. (2000) (205)
Binding of C3 fragments on top of adsorbed plasma proteins during complement activation on a model biomaterial surface. (2005) (181)
Innate immunity activation on biomaterial surfaces: a mechanistic model and coping strategies. (2011) (177)
Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation. (2003) (174)
Compstatin: a C3‐targeted complement inhibitor reaching its prime for bedside intervention (2015) (172)
Titanium Is a Highly Thrombogenic Biomaterial: Possible Implications for Osteogenesis (1999) (170)
Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy (2020) (167)
Control of instant blood-mediated inflammatory reaction to improve islets of Langerhans engraftment (2011) (163)
Optimising islet engraftment is critical for successful clinical islet transplantation (2008) (163)
An international serum standard for application in assays to detect human complement activation products. (2013) (159)
Positron Emission Tomography in Clinical Islet Transplantation (2009) (154)
C3 Adsorbed to a Polymer Surface Can Form an Initiating Alternative Pathway Convertase1 (2002) (144)
Intramuscular Autotransplantation of Pancreatic Islets in a 7‐Year‐Old Child: A 2‐Year Follow‐Up (2008) (143)
The tick-over theory revisited: formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb). (2008) (142)
Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study (2011) (142)
Complement activation triggered by chondroitin sulfate released by thrombin receptor‐activated platelets (2008) (140)
Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition? (2010) (140)
Enhanced local production of complement components in the small intestines of patients with Crohn's disease. (1990) (135)
Nicotinamide inhibits tissue factor expression in isolated human pancreatic islets: implications for clinical islet transplantation1 (2003) (131)
Complement analysis in the 21st century. (2007) (130)
Mesenchymal Stromal Cells Engage Complement and Complement Receptor Bearing Innate Effector Cells to Modulate Immune Responses (2011) (130)
Generation of iC3 at the Interface between Blood and Gas (1992) (129)
Low Molecular Weight Dextran Sulfate: A Strong Candidate Drug to Block IBMIR in Clinical Islet Transplantation (2006) (128)
A new in vitro model to study interaction between whole blood and biomaterials. Studies of platelet and coagulation activation and the effect of aspirin. (1999) (128)
The Chemotactic Response of Vibrio anguillarum to Fish Intestinal Mucus Is Mediated by a Combination of Multiple Mucus Components (1999) (127)
DEATH BY GRAFT‐VERSUS‐HOST DISEASE ASSOCIATED WITH HLA MISMATCH, HIGH RECIPIENT AGE, LOW MARROW CELL DOSE, AND SPLENECTOMY (1985) (125)
Dissecting the instant blood‐mediated inflammatory reaction in islet xenotransplantation (2008) (124)
TISSUE FACTOR RELEASED BY THE ENDOCRINE CELLS OF THE ISLETS OF LANGERHANS IS ASSOCIATED WITH A NEGATIVE OUTCOME OF CLINICAL ISLET TRANSPLANTATION (2004) (124)
Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an FcγRII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE (2003) (123)
The role of whole blood in thrombin generation in contact with various titanium surfaces. (2007) (120)
The tick-over theory revisited: is C3 a contact-activated protein? (2012) (119)
Simplified assays of hemolytic activity of the classical and alternative complement pathways. (1984) (117)
Formation of Composite Endothelial Cell–Mesenchymal Stem Cell Islets (2008) (114)
Dangerous liaisons: complement, coagulation, and kallikrein/kinin cross‐talk act as a linchpin in the events leading to thromboinflammation (2016) (112)
Variables predicting deep fungal infections in bone marrow transplant recipients. (1989) (107)
Insulin-Heparin Infusions Peritransplant Substantially Improve Single-Donor Clinical Islet Transplant Success (2010) (105)
Low molecular weight dextran sulfate prevents the instant blood-mediated inflammatory reaction induced by adult porcine islets (2004) (104)
Complement Component C3 Binds to Activated Normal Platelets without Preceding Proteolytic Activation and Promotes Binding to Complement Receptor 1 (2010) (103)
An analysis of factors predisposing to chronic graft-versus-host disease. (1985) (100)
Optimal heparin surface concentration and antithrombin binding capacity as evaluated with human non-anticoagulated blood in vitro. (2003) (99)
Positron Emission Tomography: A Real-Time Tool to Quantify Early Islet Engraftment in a Preclinical Large Animal Model (2007) (97)
Conformational changes of a model protein (complement factor 3) adsorbed on hydrophilic and hydrophobic solid surfaces (1988) (96)
Quartz crystal microbalance-with dissipation monitoring (QCM-D) for real time measurements of blood coagulation density and immune complement activation on artificial surfaces. (2005) (96)
Tumor-specific deposition of immunoglobulin G and complement in papillary thyroid carcinoma. (1996) (93)
Protection of Nonself Surfaces from Complement Attack by Factor H-Binding Peptides: Implications for Therapeutic Medicine (2011) (92)
The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation (2016) (91)
Complement activation during cardiopulmonary bypass: effects of immobilized heparin. (1994) (89)
Neutrophilic granulocytes are the predominant cell type infiltrating pancreatic islets in contact with ABO‐compatible blood (2005) (88)
Risk factors for acute graft-versus-host disease in 291 consecutive HLA-identical bone marrow transplant recipients. (1995) (88)
Acute Antibody-Mediated Complement Activation Mediates Lysis of Pancreatic Islets Cells and May Cause Tissue Loss in Clinical Islet Transplantation (2008) (87)
Compstatin Inhibits Complement and Cellular Activation in Whole Blood in Two Models of Extracorporeal Circulation (1998) (86)
The role of complement factor C3 in lipid metabolism. (2015) (86)
The Instant Blood-Mediated Inflammatory Reaction Characterized in Hepatocyte Transplantation (2011) (81)
Current status of clinical islet transplantation. (2005) (79)
Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation. (1998) (78)
Platelets, complement, and contact activation: partners in inflammation and thrombosis. (2012) (75)
C3 and C4 are strongly related to adipose tissue variables and cardiovascular risk factors (2014) (73)
The Human Platelet as an Innate Immune Cell: Interactions Between Activated Platelets and the Complement System (2019) (73)
Material-specific thrombin generation following contact between metal surfaces and whole blood. (2005) (72)
Regulated Extracellular Choline Acetyltransferase Activity— The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway (2013) (71)
Composite Islet‐Endothelial Cell Grafts: A Novel Approach to Counteract Innate Immunity in Islet Transplantation (2005) (71)
Properdin in complement activation and tissue injury. (2013) (70)
Prompt reversal of a severe complement activation by eculizumab in a patient undergoing intentional ABO‐incompatible pancreas and kidney transplantation (2011) (69)
Complement Diagnostics: Concepts, Indications, and Practical Guidelines (2012) (68)
Serum immunocomplexes in patients with subarachnoid hemorrhage. (1986) (67)
Complement C3b interactions studied with surface plasmon resonance technique. (2001) (66)
Interpretation of Serological Complement Biomarkers in Disease (2018) (66)
EXPRESSION OF COMPLEMENT REGULATORY PROTEINS ON ISLETS OF LANGERHANS: A COMPARISON BETWEEN HUMAN ISLETS AND ISLETS ISOLATED FROM NORMAL AND hDAF TRANSGENIC PIGS1 (2001) (65)
Complement analysis 2016: Clinical indications, laboratory diagnostics and quality control. (2016) (65)
Microencapsulation of cells, including islets, within stable ultra-thin membranes of maleimide-conjugated PEG-lipid with multifunctional crosslinkers. (2013) (65)
Tubing loops as a model for cardiopulmonary bypass circuits: Both the biomaterial and the blood-gas phase interfaces induce complement activation in anin vitro model (1996) (64)
Immunological recovery after bone marrow transplantation: role of age, graft-versus-host disease, prednisolone treatment and infections. (1987) (63)
Binding of a model regulator of complement activation (RCA) to a biomaterial surface: surface-bound factor H inhibits complement activation. (2001) (63)
A European multicenter study of chronic graft-versus-host disease. The role of cytomegalovirus serology in recipients and donors--acute graft-versus-host disease, and splenectomy. (1990) (62)
Mannose-Binding Lectin is Associated with Thrombosis and Coagulopathy in Critically Ill COVID-19 Patients (2020) (60)
Cardiovascular disease in haemodialysis: role of the intravascular innate immune system (2017) (60)
Anchoring of vascular endothelial growth factor to surface-immobilized heparin on pancreatic islets: implications for stimulating islet angiogenesis. (2010) (59)
Targeting Complement Pathways in Polytrauma- and Sepsis-Induced Multiple-Organ Dysfunction (2019) (59)
Multifunctional Hyaluronic Acid and Chondroitin Sulfate Nanoparticles: Impact of Glycosaminoglycan Presentation on Receptor Mediated Cellular Uptake and Immune Activation. (2016) (58)
Contact between a polymer and whole blood: sequence of events leading to thrombin generation. (2001) (58)
Blood protein-polymer adsorption: implications for understanding complement-mediated hemoincompatibility. (2011) (58)
Do ABO Blood Group Antigens Hamper the Therapeutic Efficacy of Mesenchymal Stromal Cells? (2014) (58)
Complement and platelets: Mutual interference in the immune network. (2015) (58)
Double-Detargeted Oncolytic Adenovirus Shows Replication Arrest in Liver Cells and Retains Neuroendocrine Cell Killing Ability (2010) (57)
The multifaceted role of complement in kidney transplantation (2018) (56)
Dispersion of TiO2 nanoparticles improves burn wound healing and tissue regeneration through specific interaction with blood serum proteins (2017) (55)
Safe engineering of CAR T cells for adoptive cell therapy of cancer using long‐term episomal gene transfer (2016) (55)
Activated human platelets induce factor XIIa-mediated contact activation. (2010) (55)
Modification of the Complement Binding Properties of Polystyrene: Effects of End‐Point Heparin Attachment (1993) (55)
Evidence for iC3 generation during cardiopulmonary bypass as the result of blood‐gas interaction (1993) (54)
Autoregulation of thromboinflammation on biomaterial surfaces by a multicomponent therapeutic coating (2012) (52)
Association between ongoing anti-C1q antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus. (1997) (52)
VARIABLES PREDICTING BACTERIAL AND FUNGAL INFECTIONS AFTER ALLOGENEIC MARROW ENGRAFTMENT (1987) (50)
Complement Component C3 and Butyrylcholinesterase Activity Are Associated with Neurodegeneration and Clinical Disability in Multiple Sclerosis (2015) (50)
Attenuation of Cross-Talk Between the Complement and Coagulation Cascades by C5a Blockade Improves Early Outcomes After Intraportal Islet Transplantation (2010) (50)
Inhibition of complement activation by soluble recombinant CR1 under conditions resembling those in a cardiopulmonary circuit: reduced up-regulation of CD11b and complete abrogation of binding of PMNs to the biomaterial surface. (1997) (49)
Complement C5a Functions as a Master Switch for the pH Balance in Neutrophils Exerting Fundamental Immunometabolic Effects (2017) (49)
Prediction of inflammatory responses induced by biomaterials in contact with human blood using protein fingerprint from plasma. (2015) (49)
Complement activation by polymethyl methacrylate minimized by end-point heparin attachment. (1993) (47)
Intraportal pig islet xenotransplantation into athymic mice as an in vivo model for the study of the instant blood‐mediated inflammatory reaction (2004) (47)
Pretransplant herpesvirus serology and acute graft-versus-host disease. (1988) (47)
Expression of the C5a receptor (CD88) on granulocytes and monocytes in patients with severe sepsis (2002) (47)
Contribution of Chondroitin Sulfate A to the Binding of Complement Proteins to Activated Platelets (2010) (47)
A novel TARP-promoter-based adenovirus against hormone-dependent and hormone-refractory prostate cancer. (2004) (47)
A role of herpes virus serology for the development of acute graft-versus-host disease. Leukaemia Working Party of the European Group for Bone Marrow Transplantation. (1990) (46)
Combining CAR T cells and the Bcl-2 family apoptosis inhibitor ABT-737 for treating B-cell malignancy (2013) (46)
Immunopathophysiology of trauma-related acute kidney injury (2020) (45)
Surface-attached PEO in the form of activated Pluronic with immobilized factor H reduces both coagulation and complement activation in a whole-blood model. (2006) (45)
Platelet count and function in paediatric cardiac surgery: a prospective observational study. (2014) (45)
Preparatory studies of composite mesenchymal stem cell islets for application in intraportal islet transplantation (2011) (45)
Cereal fructosans: Part 2—Characterization and structure of wheat fructosans (1986) (44)
Conformational epitopes of C3 reflecting its mode of binding to an artificial polymer surface. (1993) (44)
Type 1 Diabetes Mellitus Donor Mesenchymal Stromal Cells Exhibit Comparable Potency to Healthy Controls In Vitro (2016) (43)
Distinctive regulation of contact activation by antithrombin and C1-inhibitor on activated platelets and material surfaces. (2009) (41)
Complement Activation by CpG in a Human Whole Blood Loop System: Mechanisms and Immunomodulatory Effects1 (2009) (41)
Thrombotic disease in systemic lupus erythematosus is associated with a maintained systemic platelet activation (2004) (41)
The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System (2021) (41)
Activated Platelets Provide a Functional Microenvironment for the Antiangiogenic Fragment of Histidine-Rich Glycoprotein (2009) (41)
Phosphorylation of complement component C3 and C3 fragments by a human platelet protein kinase. Inhibition of factor I-mediated cleavage of C3b. (1995) (40)
An ex vivo loop system models the toxicity and efficacy of PEGylated and unmodified adenovirus serotype 5 in whole human blood (2010) (40)
Evaluation of the blood compatibility of materials, cells, and tissues: basic concepts, test models, and practical guidelines. (2013) (40)
An oncolytic conditionally replicating adenovirus for hormone-dependent and hormone-independent prostate cancer (2006) (40)
The importance of pre bone marrow transplantation serology in determining subsequent cytomegalovirus infection. An analysis of risk factors. (1986) (40)
An ex vivo loop system models the toxicity and efficacy of PEGylated and unmodified adenovirus serotype 5 in whole human blood (2010) (40)
TiO2 nanoparticles tested in a novel screening whole human blood model of toxicity trigger adverse activation of the kallikrein system at low concentrations. (2015) (39)
Large-Scale Comparison of Liberase HI and Collagenase NB1 Utilized for Human Islet Isolation (2010) (39)
Production of mouse monoclonal antibodies that detect distinct neoantigenic epitopes on bound C3b and iC3b but not on the corresponding soluble fragments. (1987) (39)
Mediation of a non-proteolytic activation of complement component C3 by phospholipid vesicles. (2014) (38)
Safety profile after prolonged C3 inhibition. (2018) (38)
Adenovirus with Hexon Tat-Protein Transduction Domain Modification Exhibits Increased Therapeutic Effect in Experimental Neuroblastoma and Neuroendocrine Tumors (2011) (38)
Low-molecular weight dextran sulfate abrogates the instant blood-mediated inflammatory reaction induced by adult porcine islets both in vitro and in vivo. (2004) (37)
Increased therapeutic efficacy of the prostate-specific oncolytic adenovirus Ad[I/PPT-E1A] by reduction of the insulator size and introduction of the full-length E3 region (2008) (37)
Alterations in C3 activation and binding caused by phosphorylation by a casein kinase released from activated human platelets. (1999) (37)
Chondroitin sulfate coated gold nanoparticles: a new strategy to resolve multidrug resistance and thromboinflammation. (2016) (36)
Structural and functional analysis of C3 using monoclonal antibodies. (1990) (36)
The creation of an antithrombotic surface by apyrase immobilization. (2010) (36)
Improving islet transplantation: a road map for a widespread application for the cure of persons with type I diabetes (2009) (35)
An Assessment of the Extent of Antigenic Analogy between Physiologically Bound C3 and C3 Denatured by Sodium Dodecyl Sulphate (1985) (35)
Nanoporesize affects complement activation. (2008) (34)
Allogeneic bone marrow transplantation for leukemia: factors of importance for long-term survival and relapse. (1988) (33)
Protective Effects of the Complement Inhibitor Compstatin CP40 in Hemorrhagic Shock (2018) (33)
Heparin-coated cardiopulmonary bypass circuits reduce circulating complement factors and interleukin-6 in paediatric heart surgery. (2000) (33)
Vitacyte collagenase HA: a novel enzyme blend for efficient human islet isolation. (2009) (33)
In vitro phosphorylation of human complement factor C3 by protein kinase A and protein kinase C. Effects on the classical and alternative pathways. (1990) (33)
A new method for incorporating functional heparin onto the surface of islets of Langerhans. (2008) (33)
Adenovirus Serotype 5 Vectors with Tat-PTD Modified Hexon and Serotype 35 Fiber Show Greatly Enhanced Transduction Capacity of Primary Cell Cultures (2013) (32)
Quality of life in children with hypoplastic left heart syndrome (2007) (32)
Oncolytic adenovirus modified with somatostatin motifs for selective infection of neuroendocrine tumor cells (2011) (31)
Low molecular weight dextran sulfate as complement inhibitor and cytoprotectant in solid organ and islet transplantation. (2008) (31)
Contact activation of C3 enables tethering between activated platelets and polymorphonuclear leukocytes via CD11b/CD18 (2015) (31)
Inhibition of factor I by diisopropylfluorophosphate. Evidence of conformational changes in factor I induced by C3b and additional studies on the specificity of factor I. (1990) (30)
Neoantigens in complement component C3 as detected by monoclonal antibodies. Mapping of the recognized epitopes by synthetic peptides. (1990) (30)
Preclinical evaluation of innate immunity to baculovirus gene therapy vectors in whole human blood. (2009) (30)
Interleukin 8 Elicits Rapid Physiological Changes in Neutrophils That Are Altered by Inflammatory Conditions (2021) (30)
Increased phosphate content in complement component C3, fibrinogen, vitronectin, and other plasma proteins in systemic lupus erythematosus: covariation with platelet activation and possible association with thrombosis. (1997) (30)
T cells engineered with a T cell receptor against the prostate antigen TARP specifically kill HLA-A2+ prostate and breast cancer cells (2012) (29)
Outcome of renal transplantation in patients over the age of 60: a case-control study. (1995) (29)
Effects of streptozotocin-induced diabetes in domestic pigs with focus on the amino acid metabolism (2009) (29)
The instant blood‐mediated inflammatory reaction in xenogeneic islet transplantation (2008) (29)
Auxiliary activation of the complement system and its importance for the pathophysiology of clinical conditions (2017) (28)
Desensitization With Antigen-Specific Immunoadsorption Interferes With Complement in ABO-Incompatible Kidney Transplantation (2012) (28)
Clinical adenoviral gene therapy for prostate cancer. (2010) (28)
Is generation of C3(H2O) necessary for activation of the alternative pathway in real life? (2019) (28)
Complement Activation on Radio Frequency Plasma Modified Polystyrene Surfaces (1993) (27)
A simplified assay for the detection of C3a in human plasma employing a monoclonal antibody raised against denatured C3. (1988) (27)
Transplanted Functional Islet Mass: Donor, Islet Preparation, and Recipient Factors Influence Early Graft Function in Islet-After-Kidney Patients (2012) (27)
Role of antibody synthesis and complement activation in concordant xenograft retransplantation. (1994) (27)
Complement inhibition in biomaterial- and biosurface-induced thromboinflammation (2016) (27)
Phosphorylation of complement component C3 after synthesis in U937 cells by a putative protein kinase, casein kinase 2, which is regulated by CD11b: evidence that membrane-bound proteases preferentially cleave phosphorylated C3. (1997) (27)
Complement activation products in liquid stored plasma and C3a kinetics after transfusion of autologous plasma (2012) (26)
Inhibition of complement activation on a model biomaterial surface by streptococcal M protein-derived peptides. (2009) (26)
Cryoglobulin‐induced cytokine production via FcγRIIa: inverse effects of complement blockade on the production of TNF‐α and IL‐10. Implications for the growth of malignant B‐cell clones (2005) (26)
Assessment of the Role of C3(H2O) in the Alternative Pathway (2020) (26)
Analogous antigenic alterations elicited in C3 by physiologic binding and by denaturation in the presence of sodium dodecylsulfate. (1982) (26)
Phosphoryl choline introduces dual activity in biomimetic ionomers. (2004) (25)
The role and regulation of complement activation as part of the thromboinflammation elicited in cell therapies. (2014) (25)
Thromboinflammation in Therapeutic Medicine. (2015) (25)
No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits. (2000) (25)
Hereditary dysfunction of the third component of complement associated with a systemic lupus erythematosus-like syndrome and meningococcal meningitis. (1992) (24)
Complement Activation During Liver Transplantation—Special Emphasis on Patients With Atypical Hemolytic Uremic Syndrome (2011) (24)
Open Randomized Multicenter Study to Evaluate Safety and Efficacy of Low Molecular Weight Sulfated Dextran in Islet Transplantation (2019) (23)
Immune complex‐stimulated production of interleukin‐12 in peripheral blood mononuclear cells is regulated by the complement system (2004) (23)
Influence of persistent organic pollutants on the complement system in a population-based human sample. (2014) (22)
Use of Serum or Buffer-Changed EDTA-Plasma in a Rapid, Inexpensive, and Easy-To-Perform Hemolytic Complement Assay for Differential Diagnosis of Systemic Lupus Erythematosus and Monitoring of Patients with the Disease (2007) (22)
Contact activation products are new potential biomarkers to evaluate the risk of thrombotic events in systemic lupus erythematosus (2013) (22)
Low affinity binding of plasma proteins to lipid-coated quantum dots as observed by in situ fluorescence correlation spectroscopy. (2015) (22)
Variables predicting oral mucosal lesions in allogenic bone marrow recipients (1991) (22)
Vascular repair utilising immobilised heparin conjugate for protection against early activation of inflammation and coagulation (2015) (22)
Conformational differences between surface-bound and fluid-phase complement-component-C3 fragments. Epitope mapping by cDNA expression. (1992) (22)
KEY FACTORS FOR HUMAN ISLET ISOLATION AND CLINICAL TRANSPLANTATION (2004) (22)
Validation of an MPC Polymer Coating to Attenuate Surface-Induced Crosstalk between the Complement and Coagulation Systems in Whole Blood in In Vitro and In Vivo Models. (2019) (22)
Unexpected effects of donor gender on the storage of liquid plasma (2007) (21)
Detection and characterization of immunoconglutinins in patients with systemic lupus erythematosus (SLE): serial analysis in relation to disease course (1992) (21)
Heparinization of cell surfaces with short peptide-conjugated PEG-lipid regulates thromboinflammation in transplantation of human MSCs and hepatocytes. (2016) (21)
Blood type A associates with critical COVID-19 and death in a Swedish cohort (2020) (21)
Attachment of flexible heparin chains to gelatin scaffolds improves endothelial cell infiltration. (2013) (20)
Low Molecular Weight Dextran Sulfate Is Well Tolerated in Humans and Increases Endogenous Expression of Islet Protective Hepatocyte Growth Factor (2008) (20)
The link between morphology and complement in ocular disease (2017) (20)
Short‐Term Kinetics of the Humoral Anti‐Clq Response in SLE Using the ELISPOT Method: Fast Decline in Production in Response to Steroids (1994) (20)
Reciprocal relationship between contact and complement system activation on artificial polymers exposed to whole human blood. (2016) (19)
Phosphorylation of C3 by a casein kinase released from activated human platelets increases opsonization of immune complexes and binding to complement receptor type 1 (2001) (19)
C3-targeted therapy in periodontal disease: moving closer to the clinic. (2021) (19)
Complement Receptor 2 is increased in cerebrospinal fluid of multiple sclerosis patients and regulates C3 function. (2016) (19)
Pretransplant herpes virus serology and chronic graft-versus-host disease. (1989) (19)
Phosphorylation of Coagulation Factor XI by a Casein Kinase Released by Activated Human Platelets Increases Its Susceptibility to Activation by Factor XIIa and Thrombin (1999) (19)
Tricuspid valve insufficiency as a complication of endomyocardial biopsy. (1992) (19)
Harnessing hyaluronic acid-based nanoparticles for combination therapy: A novel approach for suppressing systemic inflammation and to promote antitumor macrophage polarization. (2020) (18)
Rare Loss-of-Function Mutation in Complement Component C3 Provides Insight into Molecular and Pathophysiological Determinants of Complement Activity (2015) (18)
A human whole-blood model to study the activation of innate immunity system triggered by nanoparticles as a demonstrator for toxicity (2019) (18)
SDS denaturation of complement factor C3 as a model for allosteric modifications occurring during C3b binding: demonstration of a profound conformational change by means of circular dichroism and quantitative immunoprecipitation. (1986) (18)
Defective Fc receptor-mediated clearance in patients with primary biliary cirrhosis. (1991) (17)
Complement analysis in the 21 st century (2007) (17)
Complement as driver of systemic inflammation and organ failure in trauma, burn, and sepsis (2021) (17)
Cell Surface Engineering for Regulation of Immune Reactions in Cell Therapy. (2015) (17)
Identification of complement activators and elucidation of the fate of complement activation products during extracorporeal plasma purification therapy (1998) (17)
Changing Epidemiology of Hypoplastic Left Heart Syndrome: Results of a National Swedish Cohort Study (2019) (17)
Immune Responses to Biosurfaces (2015) (16)
Cell Adhesion Induced Using Surface Modification with Cell-Penetrating Peptide-Conjugated Poly(ethylene glycol)-Lipid: A New Cell Glue for 3D Cell-Based Structures. (2017) (16)
Contact (kallikrein/kinin) system activation in whole human blood induced by low concentrations of α-Fe2O3 nanoparticles. (2017) (16)
Blood transfusion in marrow graft recipients (1992) (15)
Phosphorylation of plasma proteins with emphasis on complement component C3. (1999) (15)
Characterization of Innate Immunity in an Extended Whole Blood Model of Human Islet Allotransplantation (2016) (15)
The impact of pretransplant herpesvirus serology on acute and chronic graft-versus-host disease. Leukaemia Working Party of the European Group for Bone Marrow Transplantation. (1990) (15)
Fc receptor function and circulating immune complexes in gluten sensitive enteropathy--possible significance of serum IgA. (1991) (15)
Purification and characterization of IgG immunoconglutinins from patien with systemic lupus erythematosus: implications for a regulatory functiot (1990) (15)
Insulin and amino acid infusion after cardiac operations: effects on systemic and renal perfusion. (1997) (15)
A high blood level in the venous chamber and a wet‐stored dialyzer help to reduce exposure for microemboli during hemodialysis (2013) (14)
Two conformational forms of target-bound iC3b that distinctively bind complement receptors 1 and 2 and two specific monoclonal antibodies (2011) (14)
Complement Killing of Yersinia enterocolitica and Retention of the Bacteria by Leucocyte Removal Filters (1994) (14)
Immune complex-mediated cytokine production is regulated by classical complement activation both in vivo and in vitro. (2008) (14)
Evaluation of a Novel Immunoassay for Quantification of C1q for Clinical Diagnostic Use (2019) (14)
Soluble complement receptor 1 (TP10) preserves adult porcine islet morphology after intraportal transplantation into cynomolgus monkeys. (2001) (14)
Animal-Free Human Whole Blood Sepsis Model to Study Changes in Innate Immunity (2020) (13)
Components of the alternative pathway. (1998) (13)
Identification of a nonproteolytically activated C3 with CR 1-binding properties in sera from subjects with primary biliary cirrhosis. (1986) (13)
Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus (2020) (13)
A study of the physiological consequences of sympathetic denervation of the heart caused by the arterial switch procedure (2010) (13)
Complement C3 inhibition in severe COVID-19 using compstatin AMY-101 (2022) (12)
Current and Future Approaches for Monitoring Responses to Anti-complement Therapeutics (2019) (12)
Surface-adsorbed fibrinogen and fibrin may activate the contact activation system. (2008) (12)
Distinctive expression of neoantigenic C3(D) epitopes on bound C3 following activation and binding to different target surfaces in normal and pathological human sera. (1989) (12)
Identification of complement C3 as an autoantigen in inflammatory bowel disease (2010) (12)
A Novel In vitro Model for Studying the Interactions Between Human Whole Blood and Endothelium (2014) (12)
Promotion of cell membrane fusion by cell-cell attachment through cell surface modification with functional peptide-PEG-lipids. (2020) (12)
Renal transplantation in elderly patients: survival and complications. (1993) (12)
Development and characterization of an innovative heparin coating to stabilize and protect liposomes against adverse immune reactions. (2016) (12)
Absence of conformational change in complement factor 3 and factor XII adsorbed to acrylate polymers is related to a high degree of polymer backbone flexibility. (2017) (11)
Correlation between anti-C1q and immune conglutinin levels, but not between levels of antibodies to the structurally related autoantigens C1q and type II collagen in SLE or RA. (1997) (11)
Pulse oximetry home monitoring in infants with single-ventricle physiology and a surgical shunt as the only source of pulmonary blood flow (2012) (11)
The recent finding that tissue factor is produced by the pancreatic islets constitutes a possible link between insulin resistance and cardiovascular disease. (2005) (11)
Tat-PTD-modified oncolytic adenovirus driven by the SCG3 promoter and ASH1 enhancer for neuroblastoma therapy. (2013) (11)
C3d-mediated negative and positive signals on the proliferation of human B cells separated from blood. (1990) (10)
Successful outcome after massive bleeding in a heart transplant recipient with mycotic aortitis. Case report. (1994) (10)
Reconstitution of the alternative pathway of complement by plasma infusions given to a patient with an SLE-like syndrome associated with a hereditary C3 dysfunction. (1994) (10)
Distribution of adoptively transferred porcine T-lymphoblasts tracked by (18)F-2-fluoro-2-deoxy-D-glucose and position emission tomography. (2011) (10)
C3-Glomerulopathy Autoantibodies Mediate Distinct Effects on Complement C3- and C5-Convertases (2019) (10)
Complement activation during tryptophan immunoadsorption treatment. (2008) (9)
Dissecting the instant blood-mediated inflammatory reaction in islet xenotransplantation (Xenotransplantation 15, 225-234) (2008) (9)
Control of IBMIR Induced by Fresh and Cryopreserved Hepatocytes by Low Molecular Weight Dextran Sulfate versus Heparin (2017) (9)
Non-proteolytically activated C3 promotes binding of activated platelets and platelet-derived microparticles to leukocytes via CD11b/CD18 (2012) (9)
Adenovirus-Mediated Expression of the Anticoagulant Hirudin in Human Islets: A Tool to Make the Islets Biocompatible to Blood (2006) (9)
Antigens of Complement Factor C3 Involved in the Interactions with Factors I and H (1986) (9)
Development of an Immunoassay for the Detection of Minute Amounts of IgG‐Coated Erythrocytes in Whole Blood and Its Application for the Assessment of Fc‐Mediated Clearance of Anti‐D‐Coated Erythrocytes in vivo (1989) (9)
Complement receptor 2 is up regulated in the spinal cord following nerve root injury and modulates the spinal cord response (2015) (9)
Anti-idiotypic antibodies in antisera against human C3 and factor H and their application in the enrichment of antibodies specific for H-binding domains of C3. (1987) (9)
Elevated NK-mediated lysis of Raji and Daudi cells carrying fixed iC3b fragments. (1989) (9)
Results of staged palliation for hypoplastic left heart syndrome: A complete population‐based series (2006) (8)
Risk factors for acute graft-versus-host disease in 325 consecutive bone marrow recipients. (1994) (8)
A new in vitro model for the study of pig‐to‐human vascular hyperacute rejection (2001) (8)
Complement C4 Copy Number Variation is Linked to SSA/Ro and SSB/La Autoantibodies in Systemic Inflammatory Autoimmune Diseases (2022) (7)
Combining CAR T cells and the Bcl-2 family apoptosis inhibitor ABT-737 for treating B-cell malignancy (2013) (7)
Is skeletal muscle luxury perfusion the main hemodynamic effect of high-dose insulin in cardiac surgery? (2000) (7)
‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (2019) (7)
Glucose-insulin-potassium (GIK) prevents derangement of myocardial metabolism in brain-dead pigs. (1994) (7)
Symptomatic cytomegalovirus infection after bone marrow transplantation (1989) (7)
Early leukemia, seropositivity for several herpes viruses and chronic graft-versus-host disease are associated with decreased incidence of relapse after allogenic bone marrow transplantation (1991) (7)
Activation of Complement C3 Does Not Hamper the Outcome of Experimental Intramuscular Islet Transplantation. (2016) (7)
Method development and validation for the quantitation of the complement inhibitor Cp40 in human and cynomolgus monkey plasma by UPLC-ESI-MS. (2017) (7)
Modification of human MSC surface with oligopeptide-PEG-lipids for selective binding to activated endothelium. (2019) (6)
Thirty-Eight-Negative Kinase 1 Is a Mediator of Acute Kidney Injury in Experimental and Clinical Traumatic Hemorrhagic Shock (2020) (6)
Transcriptome Analysis of Post-Mortem Brain Tissue Reveals Up-Regulation of the Complement Cascade in a Subgroup of Schizophrenia Patients (2021) (6)
Phenotypic alterations in circulating monocytes induced by open heart surgery using heparinized and nonheparinized cardiopulmonary bypass systems. (2008) (6)
How the Innate Immune System of the Blood Contributes to Systemic Pathology in COVID-19-Induced ARDS and Provides Potential Targets for Treatment (2022) (6)
Simultaneous generation of cytomegalovirus-specific CD8+ and CD4+ T lymphocytes by use of dendritic cells comodified with pp65 mRNA and pp65 protein. (2005) (6)
Biomaterial-dependent blood activation during simulated extracorporeal circulation: a study of heparin-coated and uncoated circuits. (1997) (6)
Corrigendum: Targeting Complement Pathways in Polytrauma- and Sepsis-Induced Multiple-Organ Dysfunction (2019) (6)
Acute early allograft failure and the C3/macrophage phenomenon. (1993) (6)
Complement Interception Across Humoral Incompatibility in Solid Organ Transplantation: A Clinical Perspective. (2015) (5)
Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19 (2022) (5)
Optimization of Islet Microencapsulation with Thin Polymer Membranes for Long-Term Stability (2019) (5)
Cell Surface Functionalization with Heparin‐Conjugated Lipid to Suppress Blood Activation (2021) (5)
Cryopreservation of mouse pancreatic islets: effects of human serum on islet survival. (1987) (5)
Porcine islets of langerhans isolated from normal and hDAF transgenic pigs elicit the same acute inflammatory reaction during exposure to human blood; inhibition of the response with soluble complement receptor 1 and heparin. (2000) (5)
Local C3 activation and macrophage accumulation in renal allografts with early vascular rejection. (1992) (5)
Immune responses to biosurfaces : mechanisms and therapeutic interventions (2015) (5)
Evidence of contact activation in patients suffering from ST-elevation myocardial infarction. (2016) (5)
Endotoxemia and complement activation after severe burn injuries-effects on leukocytes, soluble selectins, and inflammatory cytokines (1996) (5)
Pluronic Micelle-Mediated Tissue Factor Silencing Enhances Hemocompatibility, Stemness, Differentiation Potential, and Paracrine Signaling of Mesenchymal Stem Cells (2021) (5)
Author Correction: Dispersion of TiO2 nanoparticles improves burn wound healing and tissue regeneration through specific interaction with blood serum proteins (2018) (4)
Angiopoietin-2 Inhibition of Thrombomodulin-Mediated Anticoagulation—A Novel Mechanism That May Contribute to Hypercoagulation in Critically Ill COVID-19 Patients (2022) (4)
Syngeneic islet transplantations into the submandibular gland of mice. (2011) (4)
Potential of Cell Surface Engineering with Biocompatible Polymers for Biomedical Applications. (2020) (4)
Discrepancies in plasma levels of complement components measured by a newly introduced commercially available magnetic bead technique compared to presently available clinical reference intervals (2020) (4)
An Improved Method to Study Complement Receptor‐Mediated Function of the Fixed Macrophage System in vivo (1991) (4)
A Consensus Document based on the Pig‐to‐Man Islet Transplant Summit held in Stockholm, June 4–5, 2007 (2008) (4)
Oxygen affinity is decreased in patients with polycythaemia vera and essential thrombocythaemia (2004) (4)
No evidence for mosaic pathogenic copy number variations in cardiac tissue from patients with congenital heart malformations. (2015) (4)
Temperature-dependent coronary reactivity after perfusion with University of Wisconsin solution in the isolated rat heart. (1994) (4)
Identification of Metal-Binding Peptides and Their Conjugation onto Nanoparticles of Superparamagnetic Iron Oxides and Liposomes. (2020) (4)
INFLAMMATORY MEDIATORS EXPRESSED IN HUMAN ISLETS OF LANGERHANS: IMPLICATIONS FOR THE DEVELOPMENT OF AUTOIMMUNITY AND FOR ISLET TRANSPLANTATION1: 028 (2003) (4)
Improved long-term preservation of the coronary vasculature with University of Wisconsin solution. (1995) (3)
Cryoglobulins induce temperature-dependent TNF-α production via Fcγ-receptor II (2002) (3)
Interdialytic weight gain of less than 2.5% seems to limit cardiac damage during hemodialysis (2020) (3)
Defective elimination of C3b/iC3b-coated autologous erythrocytes in patients with primary biliary cirrhosis, alcoholic cirrhosis, and ulcerative colitis. (1997) (3)
Complement and Coagulation Systems Molecular Intercommunication between the (2010) (3)
Complement activation triggered by thrombin receptor-activated platelets (2007) (3)
Impaired ability of complement activation via the alternative pathway C3 convertase caused by a single-point mutation in the beta chain of C3 (2010) (3)
Transplantation of the endocrine pancreas: a new approach towards treatment of diabetes mellitus. (2009) (3)
Expression of the C 5 a receptor ( CD 88 ) on granulocytes and monocytes in patients with severe sepsis (2015) (3)
Poly(2-aminoethyl methacrylate)-based polyampholyte brush surface with carboxylic groups to improve blood compatibility (2019) (3)
Human Complement Component C3b (2005) (3)
Effect of liposome surface modification with water-soluble phospholipid polymer chain-conjugated lipids on interaction with human plasma proteins. (2021) (3)
Corrigendum to “An international serum standard for application in assays to detect human complement activation products” [Mol. Immunol. 56 (2013) 232–239] (2014) (2)
A novel model for studies of blood-mediated long-term responses to cellular transplants (2015) (2)
Polyvinylalcohol-carbazate (PVAC) reduces red blood cell hemolysis (2019) (2)
Shiga toxin 2a binds antithrombin and heparin, but does not directly activate platelets. (2018) (2)
Immune complex stimulation of peripheral blood mononuclear cells result in enhancement or suppression of IL-12 production dependent on access to a functionally active complement system (2004) (2)
The Complex Relationship between C4b-Binding Protein, Warfarin, and Antiphospholipid Antibodies (2021) (2)
Colloidal formulation of mistletoe extracts in a pharmaceutical flow process for targeted cancer therapy (2019) (2)
Low molecular weight dextran sulfate abrogates the instant blood‐mediated inflammatory reaction induced by adult porcine islets both in vitro and in vivo: 067 (2003) (2)
Isolation and preservation in vitro of human pancreatic islets intended for transplantation. (1979) (2)
Correction: Protection of nonself surfaces from complement attack by factor h-binding peptides: implications for therapeutic medicine (2012) (2)
Synthesis of poly(2-methacryloyloxyethyl phosphorylcholine)-conjugated lipids and their characterization and surface properties of modified liposomes for protein interactions. (2021) (2)
C5a receptor expression on leukocytes from patients with severe sepsis or septic shock (2001) (2)
Adenovirus with Hexon Tat-ptd Modification Exhibits Increased Therapeutic Effect in Experimental Neuroblastoma and Neuroendocrine Tumors 2 3 Short Title: Adenovirus with Hexon Tat-ptd Modification (2011) (2)
Induction of Spontaneous Liposome Adsorption by Exogenous Surface Modification with Cell-Penetrating Peptide-Conjugated Lipids. (2021) (2)
Ligands of CR2 do not interfere with C3 fragment fixation or enhanced NK sensitivity of Raji cells treated with human serum. (1989) (2)
Exposure of von Willebrand factor on isolated hepatocytes promotes tethering of platelets to the cell surface. (2019) (2)
A New Model for the Study of Vascular Hyperacute Rejection in Xenotransplantation. (1998) (1)
Factors Associated with Infections After Bone-Marrow Transplantation (1985) (1)
Autoregulation of thromboinflammation on biomaterials and cells by a novel therapeutic coating technique (2012) (1)
Variation of Complement Protein Levels in Maternal Plasma and Umbilical Cord Blood during Normal Pregnancy: An Observational Study (2022) (1)
Intercommunication between the Complement and Coagulation Systems (2010) (1)
Techniques to study functional properties of IgG preparations for parenteral use (1992) (1)
Quantitation and antigenic characterization of bound C3 of circulating immune complexes in systemic lupus erythematosus, rheumatoid arthritis, and primary biliary cirrhosis (1987) (1)
Depletion of complement in xenograft retransplantation. (1994) (1)
Therapeutic regulation of complement activation in extracorporeal circuits and intravascular treatments with special reference to the alternative pathway amplification loop (2022) (1)
The lectin complement pathway serine proteases bridges the complement and the coagulation systems in thrombotic diseases (2015) (1)
CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery (2012) (1)
Complement C3 activation in the ICU: Disease and therapy as Bonnie and Clyde. (2022) (1)
The innate immune response: A key factor in biocompatibility (2017) (1)
The lectin complement pathway serine proteases (MASPs) represent the crossroad between activation of the coagulation and complement systems (2014) (1)
Blood compatibility of widely used central venous catheters; an experimental study (2021) (1)
Quantification of Complement Proteins with Special Reference to C1q: Multiplex Versus ELISA Versus Rocket Immunoelectrophoresis Versus Nephelometry. (2021) (1)
Transplantation-free survival after Norwood surgery for hypoplastic left heart syndrome with aortic atresia: A Swedish national cohort study (2020) (1)
Monoclonal anti c3 antibodies specific for either bound or fluid phase c3 mapping of their antigenic sites in c3 by the use of an expression minilibrary (1988) (1)
Preparation of an international complement activation standard. Part two: Storage stability (2011) (1)
Double-Filter Plasmapheresis: Complement Activation in Patients with Rheumatoid Arthritis (1986) (1)
Author Correction: ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (2019) (1)
TiO2 nanoparticles tested in a nove screeing whole-blood model of toxicity trigger adverse activation of the kallikrein/kininogen system at low concentrations (2015) (1)
Complement activation on a model biomaterial surface: Binding of C3b via the alternative amplification loop to plasma proteins adsorbed to the surface (2005) (1)
Simplified hemolytic assays for the classical (CP) and alternative (AP) pathways of complement (C) (1982) (1)
Hemocompatibility of Nanotitania-Nanocellulose Hybrid Materials (2021) (1)
Immunochemical studies of interchangeable surface structures exposed by functionally distinct allosteric forms of complement factor C3 (1986) (1)
SOLUBLE COMPLEMENT RECEPTOR 1 (TP10) PRESERVES ADULT PORCINE ISLETS MORPHOLOGY AFTER INTRAPORTAL TRANSPLANTATION INTO CYNOMOLGUS MONKEYS.: Abstract# 1177 (2000) (1)
Plasma for transfusion: Effects of donor gender and different preparation and storage procedures (2007) (0)
Monitoring of pacemaker induced changes in cardiac output with inspired to endtidal oxygen difference in paediatric cardiac surgery patients (2001) (0)
Advantage with heparin-coated cardiopulmonary devices. A clinical study (1994) (0)
Tricuspid valve insufficiency as a complication of endomyocardial biopsy (1992) (0)
Transplantation-free Survival after Norwood surgery for Hypoplastic Left Heart Syndrome with Aortic Atresia. A Swedish National Cohort Study. – ERRATUM (2020) (0)
Liposomal formulations of mistletoe produced by centrifugal technologies suitable for cancer therapy (2015) (0)
Surface modulation of extracellular vesicles with cell-penetrating peptide-conjugated lipids for improvement of intracellular delivery to endothelial cells (2023) (0)
Complement system proteins in human embryonic stem cell-derived retinal pigment epithelial cells co-cultured with or without porcine retina (2017) (0)
Impairments in complement receptor- and Fc receptor-mediated functions in vivo in patients with psoriasis (2005) (0)
Functionalized Pluronic˙ as a linker for immobilization of bioactive molecules on a material surface - a new strategy towards improved biomaterial-blood compatibility (2006) (0)
Conjugation of human recombinant CD39 to primary human hepatocytes protects against thromboinflammation (2015) (0)
Defective elimination of iC3b-coated autologous erythrocytes in vivo in patients with primary biliary cirrhosis, ulcerative colitis and alcoholic cirrhosis. (1995) (0)
to Complement Receptor 1 Proteolytic Activation and Promotes Binding Preceding Activated Normal Platelets without Complement Component C3 Binds to (2010) (0)
Corrigendum (2020) (0)
Determinants of Complement Activity into Molecular and Pathophysiological InsightComplement Component C 3 Provides Rare Loss-of-Function Mutation in Ekdahl (2015) (0)
Monitoring of complement activation on a biomaterial surface (2000) (0)
AbstractAnalogous antigenic changes occurring in physiologically bound C3b-b' and detergent-treated C3 (1982) (0)
Investigation of complement activation by neutral liposomes (2012) (0)
Rare loss-of-function mutation in C3 provides insight into molecular and pathophysiological determinants of alternative pathway activity (2015) (0)
von Willebrand factor: a factor to consider in hepatocyte transplantation (2016) (0)
Formation of the fibrin network during clotting triggers factor XII-mediated contact activation and subsequent regulation by antithrombin (2011) (0)
160. Innate Immune Responses to Viral Vectors Are Modulated by Complement Inhibitors in an Ex Vivo Model Using Whole Human Blood (2006) (0)
Generation of an alternative pathway convertase by contact-activated C3 is dependent on the conformation of C3 (2018) (0)
Differential Diagnosis and Follow-up of Patients with Systemic Lupus (2007) (0)
A protective role of complement regulators linked to a PEG phospholipid construct in reducing ischemic reperfusion injury in transplantation (2017) (0)
Human Mesenchymal Stem Cells Elicit Complement Activation in Human Blood. (2009) (0)
Biomimetic polyelectrolyte coating of stem cells suppresses thrombotic activation and enhances its survival and function. (2023) (0)
The Optimization of the Hepatocyte Surface Modification Procedures in Terms of Heparin and Apyrase for Improving Hepatocyte Engraftment (2018) (0)
Distribution of lipoprotein lipase in human arteries : Relation to extracellular superoxide dismutase, apolipoprotein B and atherosclerosis (2005) (0)
High-molecular-weight PEG precipitates from synovial fluid induce more TNF-α than those from serum of RA patients, which is in contrast to patients with other inflammatory arthritides (2003) (0)
Binding of complement proteins to activated platelets is independent of complement activation (2009) (0)
iC3 generation elicited by the presence of ammonia and urea in human plasma (2015) (0)
A New Approach to Microencapsulation of Pancreatic Islets within Stable Ultra-Thin Membranes for Cell Transplantation (2013) (0)
Validations of assays for the evaluation of C1q in inflammatory diseases and thromboinflammation (2015) (0)
Co-regulation of cholinergic and complement pathways with clinical disability in Multiple Sclerosis (2015) (0)
Distinctive contact activation in systemic lupus erythematosus: The basis for new potential biomarkers to evaluate the risk of thrombotic events? (2011) (0)
Perturbed endothelial cell Blood interactions during thromboinflammation : Evaluation of a novel treatment for IRI (2015) (0)
Simplified hemolytic assays for the classical and alternative pathways of complement (1982) (0)
Two conformational forms of target bound iC3b which distinctively bind complement receptors 1 and 2 (CR1 and CR2) and two specific monoclonal antibodies. (2010) (0)
Bloodcompatibility studies of bacterial cellulose, a new biosynthetic vascular graft material (2008) (0)
Antibody preparation s whose antibodies specific to determinants of C3 b region of denatured human C3 and its priority over the front and tell accession (1986) (0)
Validation of an MPC polymer coating to reduce surface-induced cascade system activation in whole blood in in vitroand in vivo models (2019) (0)
O30 Complement deposition, C4d, on platelets is associated with vascular events and antiphospholipid antibodies in systemic lupus erythematosus (2020) (0)
PlateletsKinase Released from Activated Human Caused by Phosphorylation by a Casein Alterations in C3 Activation and Binding (1999) (0)
Auxiliary activation of the complement system and its importance for the pathophysiology of clinical conditions (2017) (0)
Forms of contact-activated C3 associated with AP convertase formation (2017) (0)
Transplantation D ASSOCIATION BETWEEN DELAYED GRAFT FUNCTION ( DGF ) AND GRAFT LOSS IN DONATION AFTER CARDIAC DEATH ( DCD ) DONOR KIDNEY TRANSPLANTS – A PAIRED (2016) (0)
Modulation of Neutrophil Activity by Soluble Complement Cleavage Products—An In-Depth Analysis (2022) (0)
Plasma concentrations of C3 and C4 are linked to cardiovascular risk factors and to the metabolic syndrome (2013) (0)
Heparinzation of cell surfaces with a heparin-binding peptide-conjugated PEG-lipid for regulation of thromboinflammation in transplantation of human MSC and hepatocyte (2015) (0)
The ratio between C4 and C4BP adsorbed from plasma predicts cytokine generation induced by artificial polymers in contact with whole blood (2012) (0)
Complement receptor 2 is up regulated in the spinal cord following nerve root injury and modulates the spinal cord response (2015) (0)
A new concept for autoregulation of complement activation on cell surfaces (2011) (0)
peptides: implications for therapeutic from complement attack by factor h-binding Correction: Protection of nonself surfaces (2013) (0)
Complement activation triggered by human mesenchymal stem cells intended for clinical use (2008) (0)
Biodegradable phosphatidylcholine functional poly(e-caprolactone) (2003) (0)
Contact between various metal surfaces and whole blood causes material-specific thrombin generation (2005) (0)
MedicinePeptides: Implications for Therapeutic Complement Attack by Factor H-Binding Protection of Nonself Surfaces from (2011) (0)
An assay to monitor in vitro generation of non-proteolytically activated C3 in human plasma (2015) (0)
C3 convertase antibodies in membranoproliferative glomerulonephritis (2013) (0)
New antigenic markers for bound and soluble activation products of C3 (1982) (0)
SP690COMPLEMENT AND CONTACT SYSTEM ACTIVATION DURING HEMODIALYSIS (2017) (0)
EVALUATION OF THE HEMOCOMPATIBILITY OF NOVEL POLYMERIC MATERIALS (2010) (0)
A model to evaluate whole blood compatibility of artificial surfaces: Effects of immobilized heparin and GPII (1997) (0)
Is the polarized secretion of complement factor H of importance in age-related macular degeneration? (2018) (0)
Dispersion of TiO2 nanoparticles improves burn wound healing and tissue regeneration through specific interaction with blood serum proteins (2017) (0)
comment ‘ Stealth ’ corporate innovation : an emerging threat for therapeutic drug development Therapeutic innovations of potentially great clinical impact should embrace the overarching values of research accountability , data transparency and validation through the scientific peer-review process (2019) (0)
Preface. 15th European Meeting on Complement in Human Disease 2015, Uppsala, Sweden. (2015) (0)
Immune complex stimulation of peripheral blood mononuclear cells result in enhancement of suppression of IL-12 production dependent on soluble serum factors (2001) (0)
Impact of spontaneous liposome modification with phospholipid polymer-lipid conjugates on protein interactions (2022) (0)
IMMOBILIZATION OF APYRASE CREATES AN ANTITHROMBOTIC BIOMATERIAL SURFACE (2010) (0)
A Robust Method to Store Complement C3 With Superior Ability to Maintain the Native Structure and Function of the Protein (2022) (0)
Surface modification of primary human hepatocytes with recombinant CD39 protects against thromboinfiammation (2015) (0)
AB1240 C4B BINDING PROTEIN AND WARFARIN IN THE ANTIPHOSPHOLIPID SYNDROME (2020) (0)
Design of a Biocompatible Extracorporeal Device for Applying Islets of Langerhans as a Bio-Artificial Pancreas (2013) (0)
A biomimetic stent coating to reduce thrombosis and inflammation (2005) (0)
Protective role of PEG conjugated phospholipid in reducing ischemic reperfusion injury in an en bloc allogeneic pig kidney transplant model (2015) (0)
Correlation between anti-C1q and immune conglutinin levels, but not between levels of antibodies to the structurally related autoantigens C1q and collagen type II in SLE or RA. (1997) (0)
The lectin complement pathway inhibitor MAP-1 is an upstream regulator of the coagulation cascade (2016) (0)
Complement activation during liver transplantation has relevance for patients with atypical hemolytic uremic syndrome (2010) (0)
Combined Heterozygous Genetic Variations in Complement C2 and C8B: An Explanation for Multidimensional Immune Imbalance? (2023) (0)
Regulated ChAT journal.pone.0065936 (2013) (0)
How COVID-19 and other pathological conditions and medical treatments activate our intravascular innate immune system (2023) (0)
Impact of surface coating and systemic anticoagulants on hemostasis and inflammation in a human whole blood model (2023) (0)
Exposure of chondroitin sulfate on activated platelets and its role in binding of complement components (2008) (0)
The lectin pathway triggered by activated platelets (2012) (0)
Protective role of PEG conjugated phospholipid in reducing ischemic reperfusion injury in two allogeneic pig kidney transplant models (2016) (0)
The lectin pathway of complement and the contact/kallikrein system are integrated (2018) (0)
Phosphorylation by a casein kinase from activated human platelets increases the binding of C3b to CR1 (2000) (0)
Author Correction: Dispersion of TiO2 nanoparticles improves burn wound healing and tissue regeneration through specific interaction with blood serum proteins (2018) (0)
The ratio between C4 and C4BP adsorbed to artificial materials is a new predictor for biocompatibility (2013) (0)
1024. An Oncolytic Conditionally Replicating Adenovirus for Hormone-Dependent and Hormone-Independent Prostate Cancer (2005) (0)
649. Increased Therapeutic Efficacy of the Prostate-Specific Oncolytic Adenovirus Ad[I/PPT-E1A] by Introduction of the Entire E3 Region or the Adenovirus Death Protein (2006) (0)
Abstract A7: TARP-TCR-engineered T cells specifically kill HLA-A2 positive prostate and breast cancer cells. (2013) (0)
Perioperative increase in plasma concentration of SC5b-9 predicts damage in transplanted liver (2011) (0)
Dimer molecular variants of apolipoprotein and processes for their production. (1992) (0)
The (y,p) reaction and the mass-dependence of meson-exchange currents (1977) (0)
Electron- and photon-induced proton knockout from Bi-209 - art. no. 014310. (2001) (0)
Transplantable functional islet mass – predictive biomarkers of graft function in islet after kidney transplanted patients (2011) (0)
DESENSITIZATION PROTOCOL WITH ANTIBODY-SPECIFIC IMMUNOABSORPTION STRONGLY INTERFERES WITH COMPLEMENT ACTIVATION IN ABO-INCOMPATIBLE KIDNEY TRANSPLANTATION: 2541 (2010) (0)
415.2: TUM012 – A New Polymer for Ex Vivo Allograft Coating To Minimize Post-reperfusion Thromboinflammation in Kidney Transplantation (2022) (0)
Adult porcine, but not rat, islets fail to cure diabetic athymic mice when transplanted via the portal vein (2003) (0)
Low molecular weight dextran sulfate unlike heparin abrogates the instant blood-mediated inflammatory reaction in pig-to-monkey pre-clinical islet xenotransplantation (2005) (0)
Low molecular weight dextran sulfate abrogates the allogeneic instant blood-mediated inflammatory reaction (IBMIR); A strong candidate drug to improve clinical islet transplantation (2006) (0)
SHORT-TERM INFUSION OF LOW MOLECULAR WEIGHT DEXTRAN SULFATE (LMW-DS) IS WELL TOLERATED IN HUMANS AND INCREASES ENDOGENOUS EXPRESSION OF ISLET PROTECTIVE HEPATOCYTE GROWTH FACTOR (HGF): 1315 (2008) (0)
ADENOVIRUS-MEDIATED EXPRESSION OF THE ANTI-COAGULANT HIRUDIN IN HUMAN PANCREATIC ISLETS. (2004) (0)
COATING OF PANCREATIC ISLETS WITH ENDOTHELIAL CELLS PRIOR TO ISLET TRANSPLANTATION: A NEW APPROACH TOWARDS IMMUNOLOGICAL PROTECTION IN THE EARLY POST TRANSPLANTATION PERIOD. (2004) (0)
422.11: Instant Post-reperfusion Thromboinflammation in Clinical Kidney Transplantation and Its Possible Impact on Outcome (2022) (0)
Characterization of the instant blood-mediated inflammatory reaction in clinical hepatocyte transplantation and identification of LMW-DS as a tentative treatment (2012) (0)
ELEVATED EXPRESSION OF MCP-1 AND TISSUE FACTOR IN PANCREATIC TISSUE CORRELATES TO TIME AT THE INTENSIVE CARE UNIT: POSSIBLE IMPLICATIONS FOR THE OUTCOME OF ISLET TRANSPLANTATION. (2004) (0)
Use of dextran sulfate for treatment of IBMIR (2003) (0)
Porcine islets of langerhans isolated from normal and hDAF transgenic pigselicit the same acute inflammatory reaction during exposure to humanblood; inhibition of the response with soluble complement (2000) (0)
Rapid Destruction of Porcine Islets of Langerhans by Fresh Human Blood. (1998) (0)
Comparison of liberase HI and collagenase NB1 in 199 human islet isolations (2009) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Bo Nilsson?

Bo Nilsson is affiliated with the following schools:

Bo Nilsson's Academic­Influence.com Rankings

Why Is Bo Nilsson Influential?

Bo Nilsson's Published Works

Published Works

What Schools Are Affiliated With Bo Nilsson?

Bo Nilsson's AcademicInfluence.com Rankings